New asthma guidelines came out in 2020, yet the answer to triple or dual inhaler therapy wasn't explicitly answered. In this episode host, Geoff Wall and guest, Jake Galdo discuss the role of triple inhaler (ICS-LABA-LAMA) in the management of severe persistent and uncontrolled asthma.

Redeem your CPE or CME credit with a GameChangers Subscription here!

We want your feedback! Share your feedback and experience with GameChangers! https://www.jotform.com/build/90155144694964

References and resources:
Kim LHY, Saleh C, Whalen-Browne A, et al. Triple vs Dual Inhaler Therapy and Asthma Outcomes in Moderate to Severe Asthma: A Systematic Review and Meta-analysis. JAMA. 2021 May 19:e217872. doi: 10.1001/jama.2021.7872. Epub ahead of print. PMID: 34009257; PMCID: PMC8135065.

Continuing Education Information:
Learning Objectives:
1. Discuss a recent study comparing triple to dual inhaler therapy in asthma
2. Describe the adverse drug events associated with triple inhaler therapy in asthma
0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-230-H01-P
Initial release date: 7/13/21
Expiration date: 7/13/22
Complete CPE & CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram